Evidence map›Paper›PMID 31185043›Full record

Trial reportPloS one2019

Working memory reflects vulnerability to early life adversity as a risk factor for substance use disorder in the FKBP5 cortisol cochaperone polymorphism, rs9296158.

William R Lovallo, Ashley Acheson, Andrew J Cohoon, Kristen H Sorocco, Andrea S Vincent, Colin A Hodgkinson, David Goldman

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

William R LovalloBehavioral Sciences Laboratories, Veterans Affairs Medical Center, Oklahoma City, OK, United States of America.ORCID 0000-0002-8489-3509
Ashley AchesonDepartment of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.
Andrew J CohoonBehavioral Sciences Laboratories, Veterans Affairs Medical Center, Oklahoma City, OK, United States of America.
Kristen H SoroccoBehavioral Sciences Laboratories, Veterans Affairs Medical Center, Oklahoma City, OK, United States of America.
Andrea S VincentCognitive Science Research Center, University of Oklahoma, Norman, OK, United States of America.
Colin A HodgkinsonLaboratory of Neurogenetics, NIH, NIAAA, Bethesda, MD, United States of America.
David GoldmanLaboratory of Neurogenetics, NIH, NIAAA, Bethesda, MD, United States of America.
Veterans Health Administration · USNational Institutes of Health · USUniversity of Arkansas for Medical Sciences · USUniversity of Oklahoma · US

Funding

Psychophysiological Precursors of AlcoholismR01AA012207 · NIAAA · UNIV OF ARKANSAS FOR MED SCIS · PI ACHESON, ASHLEY, KOCHUNOV, PETER V. · 2001 to 2025
$9.0M
NIAAA NIH HHS R01 AA012207
6 · The paper itself

Abstract

Early life adversity (ELA) negatively affects health behaviors in adulthood, but pathways from ELA exposure to behavioral outcomes are poorly understood. ELA in childhood and adolescence may translate into adult outcomes by way of modified glucocorticoid signaling. The cortisol cotransporter, FKBP5 has a G-to-A substitution (rs9296158) that hinders cortisol trafficking within target cells, and this impaired glucocorticoid signaling may shape the long-term response to ELA. We used performance on the Stroop test to assess working memory in 546 healthy young adults who had experienced 0, 1, or > 1 forms of ELA in childhood and adolescence and were genotyped for the FKBP5 rs9296158 G-to-A polymorphism. We observed a robust Gene x Environment interaction (F = 9.49, p < .0001) in which increased ELA exposure led to progressively greater Stroop interference in persons carrying AG and AA genotypes of FKBP5 with no such effect in GG carriers. Further work is needed to explore the modification of cognitive function resulting from ELA. Impairments in working memory illustrate how ELA may use glucocorticoid pathways to influence working memory with potential implications for decision-making and risky behavior including substance use disorders.

Indexed as

Memory, Short-TermPolymorphism, GeneticAdultFemaleHumansMaleRisk FactorsSubstance-Related DisordersTacrolimus Binding Protein 5Tacrolimus Binding ProteinsTacrolimus Binding Protein 5Tacrolimus Binding Proteins

Identifiers

PMID31185043
PMCPMC6559710
OpenAlexW2953310775

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.